After hitting a fresh intraday all-time high, the Dow Jones Industrial Average ultimately closed more than 500 points lower on Wednesday.

India's ambitions of becoming a global AI innovation powerhouse by building applications on top of foreign foundational models are being challenged.

The Federal Reserve and Chairman Kevin Warsh on Wednesday followed the script on interest rates closely.

JetBlue is planning to cut some employee bases at Newark Liberty International Airport in New Jersey and tech bases at New York's LaGuardia Airport.

The new leader of the Fed left interest rates alone but made clear how he plans to rewire the central bank.

The S&P 500 tumbled more than 1% in Wednesday's session, with losses steepening during Warsh' innagural press conference as chair.

Gundlach said Warsh's stance reduces the risk of overly accommodative monetary policy that could reignite inflation and push longer-term borrowing costs higher.

Elon Musk's space and AI company has seen its stock surge since its blockbuster IPO on Friday.

Allbirds became NewBird AI in April and said it would trade shoes for AI compute infrastructure.

President Trump at the G7 summit said the memorandum of understanding reached with Iran "might not be the kind of document that I should be signing."

The Federal Reserve’s rate decision on Wednesday marks the first one with Kevin Warsh at the helm.

The median projection called for the federal funds rate to end 2026 at 3.8%, a quarter percentage point above the current target range.

This is a comparison of Wednesday's Federal Open Market Committee statement with the one issued after the Fed's previous policymaking meeting in April.

The behavior of Iranian forces "has become less volatile" and the U.S. Navy continues to provide oversight, the Joint Maritime Information Center said.

Quantum computing is becoming an increasingly competitive field, with tech giants including Microsoft, Google and IBM developing the technology.

The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.

Even with global unemployment at historically low levels, workers are not feeling secure.